Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |